In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 37 for your search:
Drug:  cholecalciferol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Enrolling by invitation
Age: 20 to 79
Sponsor: Other
Protocol IDs: CKDR-001, UMIN000009970, NCT01817699

2.

Phase: Phase III, Phase II
Type: Prevention
Status: Closed
Age: 45 to 75
Sponsor: NCI, Other
Protocol IDs: 5 R01 CA098286-03, 5R01CA098286-10, NCT00153816

3.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: premenopausal
Sponsor: Other
Protocol IDs: DFCI-92044, NCI-V96-0801

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NOVARTIS-4244603039

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087

6.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069502, NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: postmenopausal
Sponsor:
Protocol IDs: CBCG-4400

8.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N02C1, NCI-2012-02515, CDR0000270449, N02C1, NCT00054418

9.

Phase: Phase III
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: BONEII, NCT00186901

10.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797

11.

Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302

12.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 02U1, NCT00058188

13.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: 2009P-001217, NCT01169259

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: IOWA-V87-0191, NCI-V87-0191

15.

Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109

16.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CPMC-IRB-94087, NCI-P97-0111

17.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and older
Sponsor:
Protocol IDs: UCMC-INT-0056, INT-0056

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: CCCWFU-29203, CCCWFU-BG03-117, NCT00068276

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: ONCO-09-99S, NCT00018538

20.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 30 to 74
Sponsor: NCI, Other
Protocol IDs: 0126-2004, R01CA104637, NCT00208793

21.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005NT018, UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, UMN-2005NT018, NCT00321932

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000554969, P30CA012197, CCCWFU-85106, CCCWFU-IRB00000371, NCT00499408

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000562742, I 95406, RPCI-I-95406, NCT00524680

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 to 85
Sponsor: Other
Protocol IDs: M2140, NCT00741364

25.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: AAAD3638, NCT00859651
1   
New Search